Literature DB >> 9692329

Design of peptides undergoing self-catalytic alpha-to-beta transition and amyloidogenesis.

H Mihara1, Y Takahashi, A Ueno.   

Abstract

Improved understanding of amyloidogenic peptides and proteins such as prion proteins and Alzheimer's beta peptides has attracted much attention to the elucidation of the molecular mechanisms of such amyloidogenesis. As a representative, in the prion protein, the conformational transitions from alpha-helix to beta-structure undergo along with the amyloidogenesis in a self-catalytic manner. Moreover, recent studies by the de novo design of peptides and proteins as well as the amyloidogenesis of peptides and proteins including pathogenic protein mutants have provided insight into the conformational changes essential to amyloidogenesis and correct folding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692329     DOI: 10.1002/(SICI)1097-0282(1998)47:1<83::AID-BIP9>3.0.CO;2-T

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  5 in total

1.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils.

Authors:  F Chiti; P Webster; N Taddei; A Clark; M Stefani; G Ramponi; C M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  De novo design of helical bundles as models for understanding protein folding and function.

Authors:  R B Hill; D P Raleigh; A Lombardi; W F DeGrado
Journal:  Acc Chem Res       Date:  2000-11       Impact factor: 22.384

3.  Proteins can convert to beta-sheet in single crystals.

Authors:  Run Zheng; Xiaojing Zheng; Jian Dong; Paul R Carey
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

4.  Stabilization of conformationally dynamic helices by covalently attached acyl chains.

Authors:  Bernhard C Poschner; Dieter Langosch
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

5.  Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.

Authors:  Létitia Jean; Benjamin Thomas; Abdessamad Tahiri-Alaoui; Michael Shaw; David J Vaux
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.